2010
DOI: 10.1016/j.expneurol.2009.09.011
|View full text |Cite
|
Sign up to set email alerts
|

GSK3: A possible link between beta amyloid peptide and tau protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
167
0
2

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 264 publications
(175 citation statements)
references
References 63 publications
6
167
0
2
Order By: Relevance
“…calcium-calmodulin kinase II (CaMKII) with KN-93, of the nonreceptor tyrosine kinases, fyn and src, with PP2, or of the cyclic AMP-dependent protein kinase A (PKA) with KT5720 blocked BrdU uptake, and thus CCR, in WT neurons. CCR was also blocked by the mTOR inhibitor, rapamycin, as reported earlier (Bhaskar et al, 2009), but not by Ag1024, an inhibitor of IGF-1 and insulin receptor kinase, which act upstream of mTOR (Zoncu et al, 2011), nor by glycogen synthase kinase3b (GSK3b) inhibitor II, which potently blocks GSK3b, a major tau kinase that can be activated by Ab (Hernández et al, 2010).…”
Section: Neuronal Ccr Requires Tausupporting
confidence: 58%
See 1 more Smart Citation
“…calcium-calmodulin kinase II (CaMKII) with KN-93, of the nonreceptor tyrosine kinases, fyn and src, with PP2, or of the cyclic AMP-dependent protein kinase A (PKA) with KT5720 blocked BrdU uptake, and thus CCR, in WT neurons. CCR was also blocked by the mTOR inhibitor, rapamycin, as reported earlier (Bhaskar et al, 2009), but not by Ag1024, an inhibitor of IGF-1 and insulin receptor kinase, which act upstream of mTOR (Zoncu et al, 2011), nor by glycogen synthase kinase3b (GSK3b) inhibitor II, which potently blocks GSK3b, a major tau kinase that can be activated by Ab (Hernández et al, 2010).…”
Section: Neuronal Ccr Requires Tausupporting
confidence: 58%
“…5B). Therefore, despite the widely recognized importance of GSK3b-catalyzed phosphorylation of tau in AD (Hernández et al, 2010), GSK3b does not appear to be involved in neuronal CCR. Secondly, the present study establishes that the CCR-mediated pathway of neurodegeneration in AD results from a direct functional link between Ab and tau, the principal building blocks of plaques and tangles.…”
Section: Discussionmentioning
confidence: 95%
“…However, neither roscovitine nor roscovitine S-isomer, two pan-cyclin-dependent kinase inhibitors included in our library, were effective against the CLuc-FGF14⅐CD4-Nav1.6-NLuc channel complex (79 Ϯ 23% S.D., n ϭ 4, and 98 Ϯ 23% S.D., n ϭ 2, respectively), providing further evidence for a GSK3-specific effect on our target. Identification of GSK3 inhibitors as hits was of particular significance due to the documented role of GSK3 in regulating neuronal polarity (30), synaptic plasticity (31), and ion channels (20) and considering its relevance as a therapeutic target against brain disorders (32,33).…”
Section: Kinase Inhibitor Screening Of the Fgf14⅐nav Channelmentioning
confidence: 99%
“…The prevalence and chronology of these phosphorylation events have been rigorously correlated with AD tangle pathology (5,6). GSK3␤ is a primary kinase for several key sites that are associated with Tau pathology, and it can lead to Tau hyperphosphorylation (37). Here, we have created a hyperphosphorylating environment for Tau by overexpressing a constitutively active form of GSK3␤.…”
Section: A Hyperphosphorylating Environment Blocks Folding Of Tau Butmentioning
confidence: 99%